By Piranha Profits Team
Last updated on April 30, 2026
|
Key Points
|
UnitedHealth Group (UNH) has been one of the most dramatic stories in large-cap investing over the past 18 months. The stock has fallen sharply from above $600 to around $354.69, driven by a perfect storm of pressures: a surge in medical costs that pushed its Medical Cost Ratio to near 89% in some quarters, a Department of Justice investigation into alleged Medicare billing fraud, and the suspension of full-year 2025 earnings guidance.
For most long-term investors, the question that follows a decline of this magnitude is always the same: what is the business actually worth?
StockOracle™'s OracleIQ™ Analysis on UnitedHealth Group (UNH)
Through StockOracle™ UnitedHealth Group's breakdown, the picture is one of a fundamentally sound business navigating an unusually difficult period.
OracleIQ™ Profitability and Financial Strength registers green, reflecting that the underlying business model remains intact. Predictability shows low with UNH's near-term earnings visibility being severely disrupted. Growth sits at medium and Valuation reflects a possible discount the market is currently applying.
Find out your favorite stocks' OracleIQ™ for Free
Revenue Growth Has Been Unbroken. The Problem Is Margins.
UnitedHealth Group (UNH) Historical Operating Revenue powered by StockOracle™ — 28th April 2026
The Financials Trend Chart illustrates what makes UNH's current situation nuanced. Revenue has grown without interruption from roughly $184 billion in 2016 to approximately $450 billion in 2025, spanning four segments: UnitedHealthcare (the insurance arm), Optum Health, Optum Insight, and Optum Rx. Geographic revenue is almost entirely United States-based, which concentrates both its opportunity and its regulatory exposure.
UnitedHealth Group (UNH) Financials Trend Chart powered by StockOracle™ — 28th April 2026
The issue isn't revenue. UnitedHealth is still a giant, but profitability has taken a hit, net income has compressed to $12,044 million on a trailing twelve-month basis, a sign that cost pressures are eating into what the business actually keeps. Until margins stabilize, any intrinsic value estimate carries a wider band of uncertainty than usual.
What Is UNH's Intrinsic Value?
UnitedHealth Group (UNH) Valuation Chart powered by StockOracle™ — 28th April 2026
The OracleValue™ for UNH currently sits at $420.21.
All growth rates and valuation outputs shown are hypothetical model inputs and not in any way a representation of forecasts or future performance.
StockOracle™'s Intrinsic Value Calculator also lets you move the inputs yourself, adjusting growth rate assumptions for Years 1 to 20 and the discount rate, and watching the output shift in real time. With UNH's near-term earnings under pressure, the difference between assuming 8% and 12% long-term net income growth produces a valuation gap. No single output should be read as a verdict.
OracleValue™ is an estimate and should not be taken as a recommendation or a signal to buy or sell stocks.
Don't borrow Wall Street's assumptions. Calculate UNH's intrinsic value your way. 7-day free trial.
Any past performance mentioned is not indicative of future results. This analysis is shared for educational purposes and is not intended as financial advice or a recommendation on any investment.
